Características químicas, mecanismo de acción y actividad antiviral de etravirina

García García, Federico; Álvarez Estévez, Marta; Guillot Suay, Vicente.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 27(supl.2): 2-5, dic. 2009. graf, ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-179463

Documentos relacionados

  1. Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs.
  2. [Chemical characteristics, mechanism of action and antiviral activity of etravirine].
  3. Cryo-EM structures of wild-type and E138K/M184I mutant HIV-1 RT/DNA complexed with inhibitors doravirine and rilpivirine.
  4. Synthesis, Characterization and Solubility Determination of 6-Phenyl-pyridazin-3(2<i>H</i>)-one in Different Pharmaceutical Solvents.
  5. Role of the K101E substitution in HIV-1 reverse transcriptase in resistance to rilpivirine and other nonnucleoside reverse transcriptase inhibitors.
  6. Synthesis and anti-HIV activity of non-nucleoside reverse-transcriptase inhibitor DB02 phosphate derivatives based on water-soluble optimization.
  7. Thiophene Ring-opening Reactions III: One-Pot Synthesis and Antitumor Activity of 1,3,4-Thiadiazoline-Benzothiazolo[3,2-<i>b</i>]pyridazine Hybrids†.
  8. Effectively predicting HIV-1 protease cleavage sites by using an ensemble learning approach.
  9. Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors by exploring the structure-activity relationship of solvent-exposed regions I.
  10. Human immunodeficiency virus 1 5'-leader mutations in plasma viruses before and after the development of reverse transcriptase inhibitor-resistance mutations.